IDEU Seminar - Group B Streptococcus and other difficult to license vaccines – what is the problem?

Monday, 15 June 2026, 1pm to 2pm

Summary: "Group B Streptococcus exemplifies the scientific, regulatory, and policy challenges of licensing vaccines where traditional efficacy trials are difficult. This talk explores barriers including low-incidence endpoints, lack of correlates of protection, and ethical constraints, and highlights emerging solutions such as immunological endpoints, serocorrelates, and innovative trial and regulatory pathways.
and bio:"

Bio: Professor Kirsty Le Doare is a paediatric infectious disease specialist and vaccinologist at City St George’s, University of London. She leads global research on maternal and neonatal immunisation, focusing on Group B Streptococcus, and advises WHO on vaccine development, policy, and implementation in low- and middle-income countries.


Professor Kirsty Mehring-Le Doare
World Health Organisation & St. George's
https://www.sgul.ac.uk/profiles/kirsty-le-doare

Speaker(s): Professor Kirsty Mehring-Le Doare

Series: IDEU Infectious Disease Seminar Series

Venue: Big Data Institute - Seminar rooms - Seminar rooms Big Data Institute Old Road Campus Oxford Oxfordshire OX3 7LF United Kingdom

Department: Nuffield Department of Population Health (Department)

Organiser: Professor Angela Brueggemann